Tech Company Financing Transactions
Saladax Biomedical Funding Round
Saladax Biomedical closed a $8.4 million Series B financing round on 12/13/2007. Investors included Delaware Crossing Investor Group and private investors.
Transaction Overview
Company Name
Announced On
12/13/2007
Transaction Type
Venture Equity
Amount
$8,400,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
116 Research Dr.
Bethlehem, PA 18015
USA
Bethlehem, PA 18015
USA
Phone
Website
Email Address
Overview
Saladax Biomedical is pioneering the development of novel, fast andinexpensive immunoassays that will enable routine blood level monitoringof anti-cancer drugs to become the standard of care in treating cancer patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Salvatore Salamone
VP - Bus. Development
DeWayne Davenport
VP - R & D
Irina Baburina
VP - Regulatory Affairs
Sue Werner
Browse more venture capital transactions:
Prev: 12/12/2007: Energy and Power Solutions venture capital transaction
Next: 12/13/2007: Fovea Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document funding rounds that are announced publicly. All VC database entries reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs